STOCK EXCHANGE: Helsinki’s strong appeal continues

The strong appeal of the Helsinki Stock Exchange continued even after the opening. The general index was quoted before one with a 1.2 percent increase at 9,730 points.

Fresh inflation figures from the euro area were received every other day. Consumer prices in the euro area were in line with economists’ expectations in December. Inflation was 2.4 percent in December, which was also in the forecasts of the consensus of economist forecasts collected by the news agency Bloomberg. Core inflation was also in line with expectations.

The top of the most traded shares had strengthened. Nordea had risen by 3.1 percent and Nokia 4.2 percent. UPM was, on the other hand, up 2.4 percent.

Course reactions and exchanges have been compiled in the table at the end of the article.

Titanium suspended the redemptions of its real estate fund

Fund company Titanium said its subsidiary Titanium Rahastoyhtiö Oy having decided to temporarily suspend its administration Special investment fund Titanium Hoivakinteistön execution of redemptions. The decision is justified by the higher-than-normal number of redemption orders and the silence of the real estate transaction market.

According to Titanium, the temporary suspension of redemptions has no effect on the fund’s value or yield. In addition, the company estimates that the temporary suspension of redemptions will not have an immediate impact on the company’s result or financial position.

The price of titanium was 5.5 percent lower in one country at 9.60 euros.

An order for Metso from India

Engineering works Roots said that he had received an order for the supply of filtration technology to an Indian project that produces iron ore pellets for the needs of the steel industry.

The value of the order is not disclosed. It is recorded in the Minerals segment’s order backlog for the fourth quarter of 2024. Delivery includes sixteen Larox FFP3512 filter presses and slurry pumps.

Metso’s share price was up 3.5 percent at 9.20 euros.

Pharmaceutical company Orion’s partner Bayer has submitted an application for the oral androgen receptor inhibitor darolutamide to the Drug Evaluation Center of China’s National Pharmaceutical Administration. Orion and Bayer are jointly developing darolutamide.

Bayer is seeking approval for the use of darolutamide in combination with the standard hormonal treatment ADT (androgen deprivation therapy) in patients with disseminated hormone-sensitive prostate cancer.

Recommendation changes

Jefferies calculates Storan Enson target price to 12.60 euros (previously 13.85 euros), buy recommendation unchanged.

Jefferies raises the target price for UPM-Kymmene to 32.20 euros (previously 31.25 euros), the buy recommendation is unchanged.

Goldman Sachs raises Konecranes target price to EUR 63.00 (previously EUR 61.00), hold recommendation unchanged.

Goldman Sachs raises Wärtsilä target price to EUR 16.10 (previously EUR 15.40), sell recommendation unchanged.

Nordea is counting of the Qt Group target price to EUR 90.00 (previously EUR 91.00), buy recommendation unchanged.

Inderes raises Sotkamo Silverin target price to SEK 1.4 (previously SEK 1.3), raising the recommendation to add (previously reduce).